Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.

Praticef: Full Drug Profile

Medically reviewed by Min Clinic Staff | Updated: January 2026

Praticef - General Information

A second-generation cephalosporin administered intravenously or intramuscularly. Its bactericidal action results from inhibition of cell wall synthesis. It is used for urinary tract infections, lower respiratory tract infections, and soft tissue and bone infections. [PubChem]

 

Pharmacology of Praticef

Praticef is a second-generation cephalosporin administered intravenously or intramuscularly. Its bactericidal action results from inhibition of cell wall synthesis. It is used for urinary tract infections, lower respiratory tract infections, and soft tissue and bone infections.

 

Additional information about Praticef

Praticef Indication

For the treatment of bacterial infections caused by susceptible microorganisms.

Mechanism Of Action
Praticef, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins.
Generic Name
Cefonicid
Synonyms
Cefonicido [inn-spanish]; Cefonicidum [inn-latin]
Drug Category
Cephalosporins; Antibacterial Agents
Drug Type
Small Molecule; Approved
Other Brand Names containing Cefonicid
Monocid; Praticef;
Protein Binding
98% bound to plasma proteins.
Biotransformation
Not metabolized.
Half Life
4.5 hours
Dosage Forms of Praticef
Solution Intramuscular
Chemical IUPAC Name
(6R,7R)-7-[(2-hydroxy-2-phenylacetyl)amino]-8-oxo-3-[[1-(sulfomethyl)tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Chemical Formula
C18H18N6O8S3
Organisms Affected
Enteric bacteria and other eubacteria